Furthermore, KEGG enrichment analysis of 786-O cells treated with an HIF-2α antagonist PT2385 (GSE153711) revealed a relationship with renal cell cancer (Fig. 1F). The gene discussed is EPAS1; the disease is renal cell adenocarcinoma.